News | September 10, 2012

Coffee Consumption Associated With Lower Death Rate

Lower death rates observed for heart disease, stroke, other diseases

September 10, 2012 — In a recent study, researchers found that coffee consumption is inversely related to mortality, with consumption of greater than or equal to six cups of coffee per day associated with a 10 percent decreased mortality rate in men and 15 percent decreased mortality in women.

Coffee is one of the most consumed beverages in the world, but drinking it can increase low-density lipoprotein (LDL) and cause short-term increases in blood pressure. Studies to date have shown conflicting results as to whether it increases heart disease risk.

The Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health study, “Association of coffee drinking with total and cause-specific mortality,”[1] followed 400,000 participants, with an average age of about 62 years on entry into the study, for 13.6 years on average to see if drinking coffee was associated with total mortality and then mortality associated with specific causes. This is the largest study to date, with 52,000 deaths documented.

The researchers found that there was a moderate inverse relationship with number of cups of coffee consumed per day and total mortality that was significant at one cup of coffee per day. The relationship strengthened as the number of cups of coffee per day increased to greater than or equal to six cups of coffee per day. Men who drank greater than or equal to six cups of coffee per day had a 10 percent lower risk of death than men who did not drink any coffee, and women in this category of consumption had a 15 percent lower risk. When specific causes of death were looked at, coffee consumption was inversely associated with heart and respiratory diseases, stroke, infections, diabetes, injuries and accidents.

Coffee consumption wasn’t associated with cancer in women, but there was a borderline positive association in men who consumed greater than or equal to six cups of coffee per day. Somehow smoking interacted with coffee consumption statistically, such that those who never smoked (both men and women) actually had a moderate inverse risk of dying from cancer. The relationship was also the same for caffeinated and decaffeinated coffee, suggesting that it was not the caffeine in coffee that was responsible for the association. Other compounds in the coffee might be responsible, such as antioxidants.

This type of study cannot prove causality, only association. It is possible that there is another unknown factor that could underlie the association that was not measured and that could explain the results. Only a double blind, placebo controlled trial (where any potential unknown factors would be randomly split among the active treatment arm and the placebo arm, and thus could not influence the results) could imply causality, and that sort of trial will probably never be done.

The results at least provide reassurance that coffee consumption is not detrimental to one’s health and may be beneficial, especially for those who have never smoked.

For more information: www.ncbi.nlm.nih.gov.webproxy.ouhsc.edu/pubmed/22591295

 

Reference:
1. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. “Association of coffee drinking with total and cause-specific mortality.” N Engl J Med. 2012 May 17;366(20):1891-904.

Related Content

First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
New Evaluation Sends Low-Risk ER Chest Pain Patients Home Sooner
News | Cardiac Diagnostics| October 10, 2017
A new evaluation to determine whether emergency room patients with chest pain can go home and follow up with their...
News | Pharmaceuticals| October 04, 2017
October 4, 2017 — MyoKardia Inc.
Medtronic Announces Post-Market Study for CoreValve Evolut Pro System
News | Heart Valve Technology| October 02, 2017
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in...
BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies| September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
News | Vena Cava Filters| September 26, 2017
September 26, 2017 — The one-year results of the SENTRY...
Treatment of Heart Attack Patients Depends on Cancer History
News | Cardio-oncology| September 26, 2017
Treatment of heart attack patients depends on their history of cancer, according to research published recently in...
CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure| September 25, 2017
BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial was presented during...
Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Overlay Init